Edited by Timo Minssen and Marcelo Corrales Compagnucci, the symposium convenes leading researchers from the International Collaborative Bioscience Innovation & Law Program (Inter-CeBIL), which is supported by a generous scientifically independent grant from the Novo Nordisk Foundation (NNF). The Inter-CeBIL initiative fosters knowledge networks to address legal and ethical challenges in health and life science innovation. It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology. Legal challenges and fragmented regulations are holding back the potential of personalized medicine. In Nature Medicine, we recently explored practical technical and legal solutions. This symposium similarly will build bridges from research to adoption.

---